Paul J Clancy Incyte Corp (INCY) insider trading activity

Paul J Clancy is Director of INCYTE CORP. Currently has a direct ownership of 19,382 shares of INCY, which is worth approximately $1.35 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 368 shares (Common Stock) at a price of $66.1 per share, resulting in proceeds of $24,324. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.4K

1.94% 3M change

29.47% 12M change

Total Value Held $1.35 Million

Paul J Clancy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	BUY Grant, award, or other acquisition	$24,324 $66.1 p/Share	368 Added 1.86%	19,382 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$24,187 $60.62 p/Share	399 Added 2.06%	19,014 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	2,830 Added 13.2%	18,615 Common Stock
Mar 28 2024	BUY Grant, award, or other acquisition	$22,958 $56.97 p/Share	403 Added 2.49%	15,785 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$25,869 $62.79 p/Share	412 Added 2.61%	15,382 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	$21,894 $57.77 p/Share	379 Added 2.47%	14,970 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$23,655 $62.25 p/Share	380 Added 2.54%	14,591 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	2,505 Added 14.99%	14,211 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$22,981 $72.27 p/Share	318 Added 2.64%	11,706 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	$23,614 $80.32 p/Share	294 Added 2.52%	11,388 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	$22,591 $66.64 p/Share	339 Added 2.97%	11,094 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$24,386 $75.97 p/Share	321 Added 2.9%	10,755 Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	2,144 Added 17.05%	10,434 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	$25,891 $79.42 p/Share	326 Added 3.78%	8,290 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$25,176 $73.4 p/Share	343 Added 4.13%	7,964 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	$22,078 $68.78 p/Share	321 Added 4.04%	7,621 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$23,809 $84.13 p/Share	283 Added 3.73%	7,300 Common Stock
May 26 2021	BUY Grant, award, or other acquisition	-	1,923 Added 21.51%	7,017 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	$24,218 $81.27 p/Share	298 Added 5.53%	5,094 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$24,441 $86.98 p/Share	281 Added 5.53%	4,796 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	$23,332 $89.74 p/Share	260 Added 5.45%	4,515 Common Stock

Also insider at

EXAS

EXACT SCIENCES CORP Healthcare

AGIO

AGIOS PHARMACEUTICALS, INC. Healthcare

Director

XLO

Xilio Therapeutics, Inc. Healthcare

PJC

Paul J Clancy

Director

Wilmington, DE

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Value

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

Operation

Value

Type

News

Receive news related to INCYTE CORP

Track Activities on INCY

Account